News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioWorld: The Billion-Plus Blockbusters: The Top 25 Biotech Drugs


8/31/2009 8:48:48 AM

Bioworld -- It's not exactly the best of times for biotechnology, although its recession-proof innovation is still in high demand. Conversely, it is not patently the worst of times for pharma, even as it swims upstream against an underway rising tide of encroaching generics, lean pipelines and innovator's block. However, it can be propitious times for both and a ground-breaking start to the future of the next new era in drug development, as collaborative, and assimilative, metrics delineate the industries that will produce therapeutics for the twenty-first century market.



comments powered by Disqus
BioWorld
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES